BSG and neoplasm: Many monoclonal antibodies for EMMPRIN have been reported to reduce MMP production by EMMPRIN in tumor cells both in vitro and in vivo[45,47-50], including the commercial anti-mouse EMMPRIN (e-Bioscience) we reported in EAE recently [25].